Literature DB >> 26339344

Corticosteroid pre-treated primary CNS lymphoma: a detailed analysis of stereotactic biopsy findings and consideration of interobserver variability.

Evrim Önder1, Ata T Arıkök1, Sevgen Önder2, Ünsal Han1, Mehmet Sorar3, Hayri Kertmen3, Engin D Yılmaz1, Ramazan Fesli3, Murat Alper1.   

Abstract

Prior corticosteroid therapy presents a major challenge in the diagnosis of CNS lymphomas, particularly in stereotactic biopsies. In this study we analysed the cytological, histopathological and immunohistochemical features in stereotactic biopsies of 25 primary CNS lymphoma cases pre-treated with corticosteroids. We documented the extent and the frequency of each finding. We also investigated the significance of subjectivity in evaluation of these biopsies in 3 seperate sessions including the final diagnostic decision. In 48% of our cases the diagnosis was straightforward. These cases were characterized by prominent blasts either in diffuse paranchymal infiltrates or in perivascular regions. The remaining 52% demonstrated some degree of variability among pathologists. Lymphoid atypia other than the typical blastic morphology appeared as a subjective finding and this was more pronounced in cytology preparations. In our study, corticosteroid pre-treatment in primary CNS lymphoma was associated with a large spectrum of histopathological, immunohistochemical and cytological findings. Combined use of an extended immunohistochemical panel would increase the possibility of conclusive diagnosis. Nevertheless some of these findings and therefore the diagnosis are open to subjectivity.

Entities:  

Keywords:  PCNSL; cytology; histopathology; immunohistochemistry; interobserver

Mesh:

Substances:

Year:  2015        PMID: 26339344      PMCID: PMC4555672     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  16 in total

1.  Diagnostic delay in primary central nervous system lymphoma.

Authors:  Ingfrid S Haldorsen; Ansgar Espeland; John Ludvig Larsen; Olav Mella
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

2.  Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells.

Authors:  Daniel Venetz; Maurilio Ponzoni; Milena Schiraldi; Andrés J M Ferreri; Francesco Bertoni; Claudio Doglioni; Mariagrazia Uguccioni
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

3.  Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.

Authors:  Wilhelm Küker; Thomas Nägele; Agnieska Korfel; Stefan Heckl; Eckhard Thiel; Michael Bamberg; Michael Weller; Ulrich Herrlinger
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

4.  Is a "vanishing tumor" always a lymphoma?

Authors:  J E C Bromberg; M D Siemers; M J B Taphoorn
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

5.  Does imprint cytology of brain tumours improve intraoperative diagnoses?

Authors:  T Brommeland; S Lindal; B Straume; I L Dahl; R Hennig
Journal:  Acta Neurol Scand       Date:  2003-09       Impact factor: 3.209

6.  Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report.

Authors:  Nancy D Doolittle; Lauren E Abrey; Tamara N Shenkier; Siegal Tali; Jacoline E C Bromberg; Edward A Neuwelt; Carole Soussain; Kristoph Jahnke; Patrick Johnston; Gerald Illerhaus; David Schiff; Tracy Batchelor; Silvia Montoto; Dale F Kraemer; Emanuele Zucca
Journal:  Blood       Date:  2007-10-25       Impact factor: 22.113

7.  Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma.

Authors:  Alyx B Porter; Caterina Giannini; Timothy Kaufmann; Claudia F Lucchinetti; Wenting Wu; Paul A Decker; John L D Atkinson; Brian Patrick O'Neill
Journal:  Ann Neurol       Date:  2008-05       Impact factor: 10.422

8.  Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas.

Authors:  M Ponzoni; F Berger; C Chassagne-Clement; M Tinguely; A Jouvet; A J M Ferreri; S Dell'Oro; M R Terreni; C Doglioni; J Weis; M Cerati; M Milani; P Iuzzolino; T Motta; A Carbone; E Pedrinis; J Sanchez; J-Y Blay; M Reni; A Conconi; F Bertoni; E Zucca; F Cavalli; B Borisch
Journal:  Br J Haematol       Date:  2007-06-07       Impact factor: 6.998

9.  Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.

Authors:  Andrés J M Ferreri; Jean-Yves Blay; Michele Reni; Felice Pasini; Michele Spina; Achille Ambrosetti; Antonello Calderoni; Andrea Rossi; Vittorio Vavassori; Annarita Conconi; Liliana Devizzi; Françoise Berger; Maurilio Ponzoni; Bettina Borisch; Marianne Tinguely; Michele Cerati; Mario Milani; Enrico Orvieto; Juvenal Sanchez; Christine Chevreau; Stefania Dell'Oro; Emanuele Zucca; Franco Cavalli
Journal:  J Clin Oncol       Date:  2003-01-15       Impact factor: 44.544

10.  Pathway analysis of primary central nervous system lymphoma.

Authors:  Han W Tun; David Personett; Karen A Baskerville; David M Menke; Kurt A Jaeckle; Pamela Kreinest; Brandy Edenfield; Abba C Zubair; Brian P O'Neill; Weil R Lai; Peter J Park; Michael McKinney
Journal:  Blood       Date:  2008-01-09       Impact factor: 22.113

View more
  15 in total

1.  Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI.

Authors:  Fu-Hua Lin; Xiang-Heng Zhang; Ji Zhang; Zhen-Qiang He; Hao Duan; Chao Ke; Ke Sai; Xiao-Bing Jiang; Fuad Al-Nahari; Shao-Yan Xi; Yong-Gao Mou
Journal:  J Neurooncol       Date:  2018-08-16       Impact factor: 4.130

2.  Brain biopsy before or after treatment with corticosteroids?

Authors:  Claire M Rice; Shelley A Renowden; Kathryn Urankar; Seth Love; Neil J Scolding
Journal:  Neuroradiology       Date:  2020-02-24       Impact factor: 2.804

3.  Presurgical Identification of Primary Central Nervous System Lymphoma with Normalized Time-Intensity Curve: A Pilot Study of a New Method to Analyze DSC-PWI.

Authors:  A Pons-Escoda; A Garcia-Ruiz; P Naval-Baudin; M Cos; N Vidal; G Plans; J Bruna; R Perez-Lopez; C Majos
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

4.  Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls.

Authors:  Iole Cordone; Serena Masi; Mariantonia Carosi; Antonello Vidiri; Francesco Marchesi; Mirella Marino; Stefano Telera; Alessia Pasquale; Andrea Mengarelli; Laura Conti; Edoardo Pescarmona; Andrea Pace; Carmine M Carapella
Journal:  J Exp Clin Cancer Res       Date:  2016-08-27

5.  Primary Central Nervous System Lymphoma in an Immunocompetent Patient Presenting as Multiple Cerebellar Lesions: A Case Report and Review of Literature.

Authors:  Gliceida M Galarza Fortuna; Kathrin Dvir; Christopher Febres-Aldana; Michael Schwartz; Ana Maria Medina
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

6.  Primary Central Nervous System Lymphoma Presenting as Multifocal Brain Abscesses.

Authors:  Sai Liang; Jia Xu Lim; Hwei Yee Lee; Sharon Yy Low
Journal:  Cureus       Date:  2020-12-14

7.  Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.

Authors:  Bradley M Downs; Wanjun Ding; Leslie M Cope; Christopher B Umbricht; Wenge Li; Huihua He; Xiaokang Ke; Matthias Holdhoff; Chetan Bettegowda; Weiping Tao; Saraswati Sukumar
Journal:  Clin Epigenetics       Date:  2021-05-05       Impact factor: 6.551

8.  Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study.

Authors:  Florian Scheichel; Franz Marhold; Daniel Pinggera; Barbara Kiesel; Tobias Rossmann; Branko Popadic; Adelheid Woehrer; Michael Weber; Melitta Kitzwoegerer; Klaus Geissler; Astrid Dopita; Stefan Oberndorfer; Wolfgang Pfisterer; Christian F Freyschlag; Georg Widhalm; Karl Ungersboeck; Karl Roessler
Journal:  BMC Cancer       Date:  2021-06-29       Impact factor: 4.430

Review 9.  New developments in the pathology of malignant lymphoma: a review of the literature published from May 2015-September 2015.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2015-11-19       Impact factor: 0.196

10.  Primary B Cell Lymphoma of the CNS Mimicking Anti-LGI1 Limbic Encephalitis.

Authors:  Christian Thomas; Christoph Lehrich; Catharina C Gross; Heinz Wiendl; Sven G Meuth; Nico Melzer
Journal:  Front Neurol       Date:  2018-08-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.